ARE (Alexandria Real Estate Equities, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by ARE officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | Blake L. Stevens | Regional Market Director | F | — | — |
| 2026-09-17 | Jenna R. Foger | EVP - Co-Lead - Life Science | F | — | — |
| 2026-09-17 | Jesse J. Nelson | EVP - RMD | F | — | — |
| 2026-09-17 | John Hart Cole | Co-President, & Co-RMD | F | — | — |
| 2026-09-17 | Gregory Calvin Thomas | EVP - CTO | F | — | — |
| 2026-09-17 | Michael E. Boss | Co-Regional Market Director | F | — | — |
| 2026-09-17 | Bret E. Gossett | EVP - Co-RMD | F | — | — |
| 2026-09-17 | Hallie E. Kuhn | EVP - Cap Market & Co-Lead -LS | F | — | — |
| 2026-09-15 | Kristina Fukuzaki-Carlson | EVP - Business Operations | Sell | — | — |
| 2026-09-15 | JOEL S MARCUS | Executive Chairman | Buy | — | — |
| 2026-09-02 | Peter M Moglia | Chief Executive Officer | F | — | — |
| 2026-09-02 | Andres Gavinet | Chief Accounting Officer | Sell | — | — |
| 2026-08-19 | JOEL S MARCUS | Executive Chairman | Buy | — | — |
| 2026-08-04 | Peter M Moglia | Chief Executive Officer | F | — | — |
| 2026-07-17 | Sheila K. McGrath | Director | A | — | — |
| 2026-07-17 | RICHARD HUNTER KLEIN | Director | A | — | — |
| 2026-07-17 | Michael A Woronoff | Director | A | — | — |
| 2026-07-17 | Steve Hash | Director | A | — | — |
| 2026-07-17 | James P Cain | Director | A | — | — |
| 2026-07-02 | Michael A Woronoff | Director | A | — | — |
| 2026-07-02 | Peter M Moglia | Chief Executive Officer | F | — | — |
| 2026-06-11 | Marc E Binda | CFO & Treasurer | Sell | — | — |
| 2026-06-02 | Peter M Moglia | Chief Executive Officer | F | — | — |
| 2026-05-07 | JOEL S MARCUS | Executive Chairman | Buy | — | — |
| 2026-05-06 | JOEL S MARCUS | Executive Chairman | Buy | — | — |
| 2026-05-05 | JOEL S MARCUS | Executive Chairman | Buy | — | — |
| 2026-05-04 | Peter M Moglia | Chief Executive Officer | F | — | — |
| 2026-05-04 | Gregory Calvin Thomas | EVP - CTO | Buy | — | — |
| 2026-04-21 | Hallie E. Kuhn | EVP - Cap Market & Co-Lead -LS | Sell | — | — |
| 2026-04-17 | RICHARD HUNTER KLEIN | Director | A | — | — |
| 2026-04-17 | Michael A Woronoff | Director | A | — | — |
| 2026-04-17 | James P Cain | Director | A | — | — |
| 2026-04-17 | Sheila K. McGrath | Director | A | — | — |
| 2026-04-17 | Steve Hash | Director | A | — | — |
| 2026-04-02 | Madeleine Thorp Alsbrook | EVP - Talent Management | A | — | — |
| 2026-04-02 | Michael E. Boss | Co-Regional Market Director | A | — | — |
| 2026-04-02 | Joshua J. Mitchell | Regional Market Director | A | — | — |
| 2026-04-02 | Gary D. Dean | EVP, Real Estate Legal Affairs | A | — | — |
| 2026-04-02 | Andres Gavinet | Chief Accounting Officer | A | — | — |
| 2026-04-02 | Gregory Calvin Thomas | EVP - CTO | A | — | — |
| 2026-04-02 | Jenna R. Foger | EVP - Co-Lead - Life Science | A | — | — |
| 2026-04-02 | Michael A Woronoff | Director | A | — | — |
| 2026-04-02 | Hallie E. Kuhn | EVP - Cap Market & Co-Lead -LS | A | — | — |
| 2026-04-02 | Peter M Moglia | Chief Executive Officer | F | — | — |
| 2026-04-02 | Orraparn C. Lee | EVP - Accounting | A | — | — |
| 2026-04-02 | Blake L. Stevens | Regional Market Director | A | — | — |
| 2026-04-02 | Jesse J. Nelson | EVP - RMD | A | — | — |
| 2026-04-02 | Joseph Hakman | Co-Chief Operating Officer | A | — | — |
| 2026-04-02 | Kristina Fukuzaki-Carlson | EVP - Business Operations | A | — | — |
| 2026-04-02 | Jackie B. Clem | General Counsel & Secretary | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Executive Chairman | 597,724 | — |
| — | Chief Executive Officer | 371,954 | — |
| — | Co-President and RMD | 237,635 | — |
| — | Co-President and RMD | 217,609 | — |
| — | CFO & Treasurer | 188,264 | — |
| — | Co-Chief Executive Officer | 173,945 | — |
| — | Former President and CFO | 172,479 | — |
| — | Co-Chief Operating Officer | 159,890 | — |
| — | Co-President | 114,994 | — |
| — | Co-President, & Co-RMD | 106,731 | — |
| — | Chief Accounting Officer | 102,516 | — |
| — | Co-Chief Operating Officer | 99,160 | — |
| — | EVP - RMD | 95,033 | — |
| — | Director | 91,760 | — |
| — | EVP - Regional Market Director | 79,283 | — |
| — | Chief Development Officer | 73,082 | — |
| — | General Counsel & Secretary | 73,044 | — |
| — | EVP - Accounting | 68,768 | — |
| — | EVP, Real Estate Legal Affairs | 68,314 | — |
| — | EVP - Co-Lead - Life Science | 67,272 | — |
| — | Co-Chief Operating Officer | 60,571 | — |
| — | EVP - Co-RMD | 52,370 | — |
| — | Co-Regional Market Director | 51,345 | — |
| — | EVP - Cap Market & Co-Lead -LS | 47,387 | — |
| — | Director | 44,000 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ARE quote page; the site-wide leaderboard is on the insider transactions hub.